TENK: TenX Keane Acquisition Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 0.00
Enterprise Value ($M) 0.75
Book Value ($M) -1.08
Book Value / Share -0.16
Price / Book 0.00
NCAV ($M) -71.71
NCAV / Share -10.78
Price / NCAV 0.00

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) 0.03
Return on Equity (ROE) 8.94

Liquidity (mrq)
Quick Ratio 0.07
Current Ratio 0.07

Balance Sheet (mrq) ($M)
Current Assets 0.09
Assets 70.71
Liabilities 71.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-07 13G/A Karpus Management, Inc. 0.00 -100.00
02-13 13G Mizuho Financial Group Inc 5.84
02-08 13G Wolverine Asset Management Llc 6.34
02-05 13G/A Space Summit Capital LLC 0.00 -100.00

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-11-20 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE)
2023-08-16 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE)
2023-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (MARK ONE)
2023-04-17 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-10 2,100 2 105,000.00

(click for more detail)

Similar Companies
TARA – Protara Therapeutics, Inc. TBPH – Theravance Biopharma, Inc.
TCRX – TScan Therapeutics, Inc. TKNO – Alpha Teknova, Inc.
TLPH – Talphera, Inc.


Financial data and stock pages provided by
Fintel.io